September 2019: New translational research projects have been selected at the Berlin Institute of Health (BIH) from a total 53 applications from the Charité and Max-Delbrück-Centrum für Molekulare Medizin (MDC). Funding recommendations were provided as part of the new funding period of the Validation Fund / SPARK-BIH. The selection procedure was supported by a diverse panel of experts with selections being made from a number of disciplines including Pharma and Med-Tech. One such project focuses on the development of an artificial heart, providing the opportunity to replace a human heart in its entirety. The total amount of funding allocated during this round is 2 million euros. This funding is allocated on the condition that teams adhere to milestones agreed upon between the parties, and will be delivered over the period of 1 or 2 years. The goal of this new funding is to bring innovative therapies to patients faster and to support translational efforts of the Charité and MDC. As part of the SPARK-BIH program, researchers receive guidance and mentorship from experienced professionals in medical product and service development.